OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases
Matilda Iemmolo, Giulio Ghersi, Giulia Bivona
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8026-8026
Open Access | Times Cited: 14
Matilda Iemmolo, Giulio Ghersi, Giulia Bivona
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8026-8026
Open Access | Times Cited: 14
Showing 14 citing articles:
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 24
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 24
CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4679-4679
Open Access | Times Cited: 15
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4679-4679
Open Access | Times Cited: 15
CX3CL1/CX3CR1 Signaling Mediated Neuroglia Activation Is Implicated in the Retinal Degeneration: A Potential Therapeutic Target to Prevent Photoreceptor Death
Jiemin Huang, Na Zhao, Xiao-Na Hao, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 1, pp. 29-29
Open Access | Times Cited: 5
Jiemin Huang, Na Zhao, Xiao-Na Hao, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 1, pp. 29-29
Open Access | Times Cited: 5
The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review
Mario Alberto Alarcón‐Sánchez, Julieta Saraí Becerra‐Ruiz, Celia Guerrero‐Velázquez, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 5
Mario Alberto Alarcón‐Sánchez, Julieta Saraí Becerra‐Ruiz, Celia Guerrero‐Velázquez, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 5
Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease
Zu-Qi Chen, Meng Ting Wang, Cheng‐Rong Tan, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Zu-Qi Chen, Meng Ting Wang, Cheng‐Rong Tan, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Nucleic Acids-Based Biomarkers for Alzheimer’s Disease Diagnosis and Novel Molecules to Treat the Disease
Giulia Bivona, Selene Sammataro, Giulio Ghersi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7893-7893
Open Access | Times Cited: 3
Giulia Bivona, Selene Sammataro, Giulio Ghersi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7893-7893
Open Access | Times Cited: 3
CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis
Dariusz Szukiewicz
(2024)
Open Access | Times Cited: 2
Dariusz Szukiewicz
(2024)
Open Access | Times Cited: 2
Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Maria L. Serradas, Yingying Ding, Paula Martorell, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1426-1426
Open Access | Times Cited: 2
Maria L. Serradas, Yingying Ding, Paula Martorell, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1426-1426
Open Access | Times Cited: 2
CX3CR1 mediates motor dysfunction in mice through 5-HTR2a
Jingchun Pei, Yongwei Zou, Cheng Wan, et al.
Behavioural Brain Research (2023) Vol. 461, pp. 114837-114837
Open Access | Times Cited: 4
Jingchun Pei, Yongwei Zou, Cheng Wan, et al.
Behavioural Brain Research (2023) Vol. 461, pp. 114837-114837
Open Access | Times Cited: 4
Serum ADAM -17 and Interleukin-6 Levels as a Predictors in Type 2 Diabetic Patients with Myocardial Infarction Patients
Maher Adnan Qalaf, Fadhil Jawad Al-Tu’ma, Maher Abbood Mukheef, et al.
Kerbala journal of pharmaceutical sciences. (2024) Vol. 14, Iss. 23, pp. 63-73
Open Access | Times Cited: 1
Maher Adnan Qalaf, Fadhil Jawad Al-Tu’ma, Maher Abbood Mukheef, et al.
Kerbala journal of pharmaceutical sciences. (2024) Vol. 14, Iss. 23, pp. 63-73
Open Access | Times Cited: 1
Anti‐inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis
Fynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Fynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Placenta-derived mesenchymal stem cells attenuate secondary brain injury after controlled cortical impact in rats by inhibiting matrix metalloproteinases
Ping Yang, YUANXIANG LAN, ZHONG ZENG, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 149-162
Open Access
Ping Yang, YUANXIANG LAN, ZHONG ZENG, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 149-162
Open Access
Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment
Vitória Mattos Pereira, Suyasha Pradhanang, Jonathan F. Prather, et al.
Current Neuropharmacology (2024) Vol. 23, Iss. 1, pp. 58-74
Closed Access
Vitória Mattos Pereira, Suyasha Pradhanang, Jonathan F. Prather, et al.
Current Neuropharmacology (2024) Vol. 23, Iss. 1, pp. 58-74
Closed Access
Ahmed M. E. Abdalla, Miao Yu, Ning Ming, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 10, pp. 907-923
Closed Access
